Information:
Fel:
ID
38243
Beskrivning
Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01232062
Länk
https://clinicaltrials.gov/show/NCT01232062
Nyckelord
Versioner (1)
- 2019-10-01 2019-10-01 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
1 oktober 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Neoplasms NCT01232062
Eligibility Breast Neoplasms NCT01232062
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT01232062
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Chemotherapy failed | Anthracyclines | Taxol
Item
failure to anthracycline and/or taxol chemotherapy;
boolean
C0392920 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0282564 (UMLS CUI [2])
C0678133 (UMLS CUI [3])
C0231175 (UMLS CUI [1,2])
C0282564 (UMLS CUI [2])
C0678133 (UMLS CUI [3])
Neoplasm Metastasis Estrogen receptor negative Immunohistochemistry | Neoplasm Metastasis Progesterone receptor negative Immunohistochemistry | HER2 Negative FISH
Item
metastatic tumor is histologically confirmed by immunohistochemical staining to be er-negative and pr-negative. fish testing for her-2-negative;
boolean
C0027627 (UMLS CUI [1,1])
C0279756 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
C0027627 (UMLS CUI [2,1])
C0279766 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
C2348908 (UMLS CUI [3,1])
C0162789 (UMLS CUI [3,2])
C0279756 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
C0027627 (UMLS CUI [2,1])
C0279766 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
C2348908 (UMLS CUI [3,1])
C0162789 (UMLS CUI [3,2])
Neoplasm Metastasis Inoperable
Item
metastatic tumor can not be removed through surgery procedure;
boolean
C0027627 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C0205187 (UMLS CUI [1,2])
Neoplasm Metastasis Size PET/CT scan
Item
metastatic tumor measured by pet-ct scan is at least 1cm;
boolean
C0027627 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
C1699633 (UMLS CUI [1,3])
C0456389 (UMLS CUI [1,2])
C1699633 (UMLS CUI [1,3])
ECOG performance status
Item
an eastern cooperative oncology group (ecog) performance status of 0-2;
boolean
C1520224 (UMLS CUI [1])
Cardiac function | Liver function | Renal function | Bone Marrow function
Item
normal cardiac, hepatic, renal and bone marrow functions;
boolean
C0232164 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0005953 (UMLS CUI [4,1])
C0031843 (UMLS CUI [4,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0005953 (UMLS CUI [4,1])
C0031843 (UMLS CUI [4,2])
Life Expectancy
Item
life expectancy ≥3 months.
boolean
C0023671 (UMLS CUI [1])
PET/CT scan Twice
Item
do not finish twice pet-ct scan;
boolean
C1699633 (UMLS CUI [1,1])
C1948050 (UMLS CUI [1,2])
C1948050 (UMLS CUI [1,2])
CNS metastases
Item
central nervous system metastases;
boolean
C0686377 (UMLS CUI [1])
Comorbidity Serious | Comorbidity Uncontrolled
Item
serious or uncontrolled concurrent medical illness;
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Cancer Other
Item
history of other malignancies;
boolean
C1707251 (UMLS CUI [1])
Study Subject Participation Status
Item
having been enrolled in some other clinal trials within a month;
boolean
C2348568 (UMLS CUI [1])